Johnson and Johnson/ US4781601046 /
04/06/2024 22:10:00 | Var. +0.06 | Volume | Denaro02:00:00 | Lettera02:00:00 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
147.80USD | +0.04% | 8.88 mill. Fatturato: 859.52 mill. |
147.83Quantità in denaro: 200 | 149.08Quantità in lettera: 100 | 355.71 bill.USD | 3.18% | 10.65 |
Newsfile Corp
08:50
Normandin Beaudry Introduces Innovative Total Rewards Programs Enhancing Employee Satisfaction
GlobeNewswire
08:30
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity f...
GlobeNewswire
08:00
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
GlobeNewswire
07:30
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR...
GlobeNewswire
07:00
HENSOLDT, Lufthansa Technik Defense and Bombardier Defense Announce Significant Progress on Global A...
GlobeNewswire
07:00
SEALSQ, WISeKey and The Hashgraph Association Join Forces to Bring Secure IoT and DePIN solutions to...
GlobeNewswire
07:00
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Co...
GlobeNewswire
07:00
Award-Winning Decision Intelligence Firm Quantexa Accelerates Global Momentum, Announces Strong FY24...
GlobeNewswire
06:08
Flash News: OKX Wallet to Host 'Runes Revolution: Is it too late?' X Spaces Discussion